Sabby Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Sabby Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42,378	Closed	-$68K	–	116
2019 Q4	$68K	Buy	+42,378	New	+$19.2K	0.02%	65
2019 Q3	–	Sell	-52,685	Closed	-$45K	–	119
2019 Q2	$45K	Buy	52,685 +19,042	+57%	+$16.7K	0.06%	79
2019 Q1	$33K	Buy	33,643 +21,597	+179%	+$23.2K	0.02%	66
2018 Q4	$10K	Buy	+12,046	New	+$23.7K	﹤0.01%	116
2018 Q1	–	Sell	-55,907	Closed	-$121K	–	232
2017 Q4	$127K	Sell	55,907 -277,734	-83%	-$605K	0.01%	130
2017 Q3	$716K	Sell	333,641 -24,151	-7%	-$50K	0.05%	89
2017 Q2	$787K	Buy	357,792 +14,370	+4%	+$35.2K	0.05%	112
2017 Q1	$972K	Sell	343,422 -153,307	-31%	-$420K	0.05%	133
2016 Q4	$1.39M	Sell	496,729 -260,304	-34%	-$737K	0.08%	130
2016 Q3	$2.35M	Buy	+757,033	New	+$2.85M	0.09%	115

Other funds holding SPHS

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ACM

AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Sabby Management's SPHS Position: Q1 2020 in Review

Sabby Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 42,378 shares — an estimated $68K sold.

Sabby Management first reported a position in SPHS in Q3 2016 and held it in 10 quarters. The position peaked at $2.35M in Q3 2016. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

Sabby Management reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
Sabby Management sold 42,378 Sophiris Bio, Inc. shares in Q1 2020, an estimated $68K.
Sabby Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 10 quarters.
Sabby Management's Sophiris Bio, Inc. position peaked at $2.35M in Q3 2016.
3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.